Search hospitals
>
Washington
>
Seattle
Fred Hutchinson Cancer Research Center
Claim this profile
Seattle, Washington 98109
Global Leader in Leukemia
Global Leader in Cancer
Conducts research for Acute Myelogenous Leukemia
Conducts research for Lymphoma
Conducts research for Breast Cancer
818 reported clinical trials
105 medical researchers
Summary
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Cancer, Acute Myelogenous Leukemia, Lymphoma, Breast Cancer and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 997 conditions. There are 105 research doctors associated with this hospital, such as Michael J Wagner, MD, Michael Schweizer, Christina S. Baik, and Jennifer M. Specht.
Area of expertise
Leukemia
Fred Hutchinson Cancer Research Center has run 209 trials for Leukemia. Some of their research focus areas include:
Cancer
Fred Hutchinson Cancer Research Center has run 206 trials for Cancer. Some of their research focus areas include:
Top PIs
Michael J Wagner, MD
Dana-Farber Cancer Institute
5 years of reported clinical research
Michael Schweizer
Fred Hutch/University of Washington Cancer Consortium
1 year of reported clinical research
Christina S. Baik
Fred Hutchinson Cancer Center
6 years of reported clinical research
Jennifer M. Specht
Seattle Cancer Care Alliance / University of Washington
3 years of reported clinical research
Clinical Trials running at Fred Hutchinson Cancer Research Center
Breast Cancer
Prostate Cancer
Breast cancer
Pancreatic Cancer
Cancer
Acute Lymphoblastic Leukemia
Lung Cancer
Acute Myeloid Leukemia
Multiple Myeloma
Leukemia
Letrozole
for Breast Cancer
This stage IV trial examines how a mutation in HSD3B1 (1245C) gene affects treatment of stage I-III breast cancer. This trial may help researchers determine if mutations in HSD3B1 decreases the efficacy of aromatase inhibitor therapy such as letrozole. Letrozole may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Recruiting
3 awards
Phase 4
10 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Recruiting
2 awards
Phase 3
11 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fred Hutchinson Cancer Research Center?
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Cancer, Acute Myelogenous Leukemia, Lymphoma, Breast Cancer and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 997 conditions. There are 105 research doctors associated with this hospital, such as Michael J Wagner, MD, Michael Schweizer, Christina S. Baik, and Jennifer M. Specht.
Where is Fred Hutchinson Cancer Research Center located?
**Fred Hutchinson Cancer Research Center** - **Address:** 1100 Fairview Ave N, Seattle, WA 98109 - **Directions:** From downtown Seattle, take the South Lake Union Streetcar to the Westlake Ave N & Mercer St stop. From there, it's a 10-minute walk northwest on Fairview Ave N.
Who should I call to ask about financial aid or insurance network?
**Fred Hutchinson Cancer Research Center Financial Assistance and Insurance Departments** - **Financial Counseling Department** - **Address:** 825 Eastlake Ave. East, Seattle, Washington, 98109 - **Phone:** (206) 606-6226 or toll-free at 1 (800) 304-1763 - **Email:** fincounsel@fredhutch.org - **Website:** [Financial Assistance Information](https://www.fredhutch.org/en/patient-care/patient-services/insurance-and-billing/financial-assistance.html) - **Patient Financial Services Department** - **Phone:** (206) 606-6226 or toll-free at 1 (800) 304-1763 - **Email:** fincounsel@fredhutch.org - **Website:** [Financial Assistance Information](https://www.fredhutch.org/en/patient-care/patient-services/insurance-and-billing/financial-assistance.html) These departments offer support with financial assistance applications, insurance queries, and billing issues.
What insurance does Fred Hutchinson Cancer Research Center accept?
The Fred Hutchinson Cancer Research Center accepts a wide range of insurance plans, including but not limited to Aetna, Allways Health Partners, Ambetter, BCBS, CIGNA, First Health, Harvard Pilgrim, Humana, MEDICA, MVP Health Plan, Medicare Advantage, Molina, Multiplan, PacificSource, Premera, Regence, Tufts, UHC, and WPS Group. Additionally, employees have the option to choose between Premera Blue Cross or Kaiser Permanente Health Plan of Washington. Premera Blue Cross plans utilize a healthcare provider network, whereas Kaiser Permanente's HMO Core Plan offers integrated services with benefits coordinated through network providers, emphasizing small copays for in-network services and emergency coverage only outside the network.
What awards or recognition has Fred Hutchinson Cancer Research Center received?
Fred Hutchinson Cancer Research Center in Seattle, Washington, is renowned for its significant contributions to cancer research and care. It has merged with Seattle Cancer Care Alliance under UW Medicine, creating a unified, independent nonprofit organization dedicated to adult cancer research and care. The center excels in business development, boasting successful ventures like Juno Therapeutics and Adaptive Biotechnologies, and actively works to improve community health through its Community Grants Program.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.